Fipronil + Pyriproxyfen + S-Methoprene

Verify with FDA CVM →

293 adverse event reports submitted to the FDA

Important: Adverse event reports do not establish that a drug caused or contributed to the event. Consult your veterinarian before making treatment decisions.
293
Total Reports
13
Deaths Reported
440.0%
Death Rate

Active Ingredients

FipronilPyriproxyfenS-Methoprene

Administration Routes

OtherTopicalUnknownOral

Species Affected

Dog 269
Cat 23
Human 1

Most Affected Breeds

Retriever - Labrador 30
Retriever - Golden 20
Shepherd Dog - German 15
Domestic Shorthair 14
Shih Tzu 12
Chihuahua 12
Crossbred Canine/dog 11
Collie - Border 9
Beagle 8
Dog (unknown) 7

Most Reported Reactions

Vomiting 43
Lethargy (see also Central nervous system depression in 'Neurological') 39
Lack of efficacy (ectoparasite) - flea 37
Seizure NOS 29
Lack of efficacy (bacteria) - NOS 23
Diarrhoea 22
Lack of efficacy (tick) 21
Lack of efficacy (bacteria) - Borrelia 16
Anorexia 14
Shaking 13
Ataxia 11
Not eating 11

Outcome Breakdown

Outcome Unknown
170 (58.0%)
Recovered/Normal
87 (29.7%)
Ongoing
23 (7.8%)
Euthanized
7 (2.4%)
Died
6 (2.0%)

Data Summary

Metric Value
Total adverse event reports 293
Reports involving death 13
Case-fatality rate (reported events) 440.0%
Distinct species in reports 3
Distinct breeds in reports 20
Distinct reactions reported 20
Active ingredients on file 3

Source: FDA Center for Veterinary Medicine — Adverse Event Reporting (CVM AER). Counts reflect voluntary reports only.

Fipronil + Pyriproxyfen + S-Methoprene Adverse Event Insights

The FDA Center for Veterinary Medicine database currently holds 293 adverse event reports referencing Fipronil + Pyriproxyfen + S-Methoprene, including 13 reports in which the animal died — a 440.0% case-fatality figure among reported events only, not a population-level mortality rate. Active ingredients on file: Fipronil, Pyriproxyfen, S-Methoprene. Reported administration routes include Other, Topical, Unknown, Oral. These numbers reflect voluntary submissions from pet owners, veterinarians, and manufacturers and therefore under-represent mild events and over-represent severe ones — a pattern the FDA has documented repeatedly for pharmacovigilance datasets.

The species most frequently named in Fipronil + Pyriproxyfen + S-Methoprene reports are Dog (269 reports), Cat (23 reports), Human (1 reports), with Dog accounting for the largest share. Within those species, Retriever - Labrador (30), Retriever - Golden (20), Shepherd Dog - German (15) appear most often — though breed popularity and ownership density shape these counts as much as any drug-specific sensitivity. This distribution matters because the same active ingredient can behave very differently across body sizes, ages, and species physiology.

The most commonly reported clinical signs associated with Fipronil + Pyriproxyfen + S-Methoprene are Vomiting (43), Lethargy (see also Central nervous system depression in 'Neurological') (39), Lack of efficacy (ectoparasite) - flea (37), Seizure NOS (29). Of the 293 reports with a coded outcome, Outcome Unknown is the leading category at 58.0%. Because FDA adverse event data describes correlation rather than causation, these figures are best used to frame informed questions with a veterinarian and to compare reporting patterns across related products — not as a standalone safety verdict on Fipronil + Pyriproxyfen + S-Methoprene.

Source: FDA Center for Veterinary Medicine — Adverse Event Reports FDA Center for Veterinary Medicine — Adverse Event Reports Data reflects voluntary submissions and may not represent actual incidence rates

Related

Data sourced from official AKC, AVMA, ACVO, and breed-club veterinary references. See our methodology for details. Retrieved and formatted by PlainBreed Editorial